SBI Healthcare Opportunities Fund - Direct Plan Growth | SBI Healthcare Opportunities Fund - Direct Plan NAV Today [467.38], Performance & History

SBI Healthcare Opportunities Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by SBI Funds Management Ltd.. Launched on 01 Jan 2013, investors can start with a minimum SIP ... Read more

NAV History

Fund Details

Min. SIP Amount

₹500

Inception Date

01 Jan 2013

Min. Lumpsum Amount

₹ 5,000

Fund Age

13 Yrs

AUM

₹ 3,989.42 Cr.

Benchmark

BSE Healthcare Total Return

Expense Ratio

0.91%

Scheme Type

Open Ended

Exit Load

0.50%

Returns Calculator

Investment amount per month

₹1,000

Over the past

Would have become

On total investment of

*Calculation based on past performance of this fund.

Asset Allocation

AUM

₹ 3,989.42 Cr

Equity

91.28%

Debt

0.08%

Money Market & Cash

3.99%

Other Assets & Liabilities

4.81%

Sector Holdings

Sectors	Weightage
Pharmaceuticals	60.97%
Hospitals & Medical Services	23.31%
Foreign Securities	4.81%
Treps/Reverse Repo	3.99%
Chemicals - Speciality	3.90%
Medical Equipment & Accessories	3.10%
Others - Not Mentioned	0.08%

See All

Stock Holdings

Name	Weightage	Value (in Cr.)	Sector
Sun Pharmaceutical Industries Ltd.	12.73%	₹ 469.73	Pharmaceuticals
Divi's Laboratories Ltd.	7.39%	₹ 272.56	Pharmaceuticals
Max Healthcare Institute Ltd.	6.40%	₹ 236.29	Hospitals & Medical Services
Lonza Group	4.81%	₹ 177.55	Others
Cipla Ltd.	4.77%	₹ 175.88	Pharmaceuticals
Lupin Ltd.	4.46%	₹ 164.45	Pharmaceuticals
TREPS	3.99%	₹ 147.23	Others
Mankind Pharma Ltd.	3.75%	₹ 138.19	Pharmaceuticals
Krishna Institute of Medical Sciences Ltd.	3.34%	₹ 123.17	Hospitals & Medical Services
Fortis Healthcare Ltd.	3.22%	₹ 118.66	Hospitals & Medical Services
Ami Organics Ltd.	3.19%	₹ 117.63	Pharmaceuticals
Jupiter Life Line Hospitals Ltd.	3.18%	₹ 117.18	Hospitals & Medical Services
Aster DM Healthcare Ltd.	3.18%	₹ 117.45	Hospitals & Medical Services
Polymedicure Ltd.	3.10%	₹ 114.41	Medical Equipment & Accessories
Abbott India Ltd.	2.97%	₹ 109.64	Pharmaceuticals
Aether Industries Ltd.	2.83%	₹ 104.32	Chemicals - Speciality
Alkem Laboratories Ltd.	2.76%	₹ 101.97	Pharmaceuticals
Torrent Pharmaceuticals Ltd.	2.58%	₹ 95.24	Pharmaceuticals
Aurobindo Pharma Ltd.	2.49%	₹ 91.82	Pharmaceuticals
Laurus Labs Ltd.	2.48%	₹ 91.44	Pharmaceuticals
Rainbow Children's Medicare Ltd.	2.43%	₹ 89.76	Hospitals & Medical Services
Gland Pharma Ltd.	2.33%	₹ 85.78	Pharmaceuticals
Concord Biotech Ltd.	1.90%	₹ 69.94	Pharmaceuticals
Biocon Ltd.	1.82%	₹ 67.17	Pharmaceuticals
Vijaya Diagnostic Centre Ltd.	1.56%	₹ 57.38	Hospitals & Medical Services
Cohance Lifesciences Ltd.	1.53%	₹ 56.58	Pharmaceuticals
Pfizer Ltd.	1.52%	₹ 56.13	Pharmaceuticals
Akums Drugs & Pharmaceuticals Ltd.	1.24%	₹ 45.71	Pharmaceuticals
Sanofi Consumer Healthcare India Ltd.	1.07%	₹ 39.51	Chemicals - Speciality
Gufic Biosciences Ltd.	1.06%	₹ 39.10	Pharmaceuticals
182 DAY T-BILL 05.06.25	0.08%	₹ 3	Others - Not Mentioned

See All

Returns

	Annualised returns
	9M	1Y	2Y	3Y
Fund returns	-2.62%	-0.51%	12.92%	23.94%
Category returns	5.58%	6.26%	12.22%	26.95%

Fund Objective

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes ... Read more

AMC Details

Name

SBI Funds Management Ltd.

Date of Incorporation

29 Jun 1987

CEO

Mr. Nand Kishore

CIO

Mr. Rajeev Radhakrishnan, Mr. Rama Iyer Srinivasan

Type

Bank Sponsored

Address

9th Floor, Crescenzo, C-38 & 39, G Block, Bandra-Kurla Complex, Bandra (East), Mumbai, Maharashtra, India - 400051

Website

https://www.sbimf.com

partnerforlife@sbimf.com

Top Funds from Equity - Sectoral/Thematic

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
ICICI Prudential Technology Fund - Direct Plan Sector Direct	₹139.08	-5.85%	32.87%	69.75%	₹15,892	0.99%	Very High
ICICI Prudential Technology Fund - Direct Plan Sector Direct	₹139.08	-5.85%	32.87%	69.75%	₹15,892	0.99%	Very High
Nippon India Banking & Financial Services Fund - Direct Plan Sector Direct	₹104.62	4.25%	32.64%	84.17%	₹7,778	0.96%	Very High
Nippon India Banking & Financial Services Fund - Direct Plan Sector Direct	₹104.62	4.25%	32.64%	84.17%	₹7,778	0.96%	Very High
Mahindra Manulife Consumption Fund - Direct Plan Diversified Direct	₹18.76	-2.41%	32.23%	65.76%	₹559	0.63%	Very High
Mahindra Manulife Consumption Fund - Direct Plan Diversified Direct	₹18.76	-2.41%	32.23%	65.76%	₹559	0.63%	Very High
ICICI Prudential Commodities Fund Diversified Regular	₹31.98	11.66%	31.66%	128.43%	₹3,409	1.96%	Very High
ICICI Prudential Commodities Fund Diversified Regular	₹31.98	11.66%	31.66%	128.43%	₹3,409	1.96%	Very High
Aditya Birla Sun Life Banking and Financial Services Fund Sector Regular	₹23.25	12.75%	31.58%	51.17%	₹3,694	1.95%	Very High
Aditya Birla Sun Life Banking and Financial Services Fund Sector Regular	₹23.25	12.75%	31.58%	51.17%	₹3,694	1.95%	Very High

Top Funds from SBI Funds Management Ltd.

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
SBI Retirement Benefit Fund - Conservative Hybrid Plan -... Hybrid Direct	₹15.95	4.43%	32.65%	0.00%	₹283	1.16%	High
SBI Retirement Benefit Fund - Conservative Hybrid Plan -... Hybrid Direct	₹15.95	4.43%	32.65%	0.00%	₹283	1.16%	High
SBI Conservative Hybrid Fund - Div (Annual) Hybrid Regular	₹26.02	6.55%	31.91%	57.02%	₹9,830	1.10%	High
SBI Conservative Hybrid Fund - Div (Annual) Hybrid Regular	₹26.02	6.55%	31.91%	57.02%	₹9,830	1.10%	High
SBI Conservative Hybrid Fund Hybrid Regular	₹21.27	6.55%	31.91%	57.01%	₹9,830	1.54%	High
SBI Conservative Hybrid Fund Hybrid Regular	₹21.27	6.55%	31.91%	57.01%	₹9,830	1.54%	High
SBI Conservative Hybrid Fund Hybrid Regular	₹73.76	6.55%	31.91%	57.01%	₹9,830	1.54%	High
SBI Retirement Benefit Fund - Conservative Hybrid Plan Hybrid Regular	₹15.48	3.92%	30.63%	0.00%	₹283	1.67%	High
SBI Retirement Benefit Fund - Conservative Hybrid Plan Hybrid Regular	₹15.48	3.92%	30.62%	0.00%	₹283	1.67%	High
SBI Credit Risk Fund - Direct Plan FRF-LT Direct	₹16.23	8.11%	28.51%	42.78%	₹2,172	0.89%	High

FAQs

What is the current NAV of SBI Healthcare Opportunities Fund - Direct Plan Growth?

The current Net Asset Value (NAV) of SBI Healthcare Opportunities Fund - Direct Plan Growth is ₹467.38 as of 31 Jan 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.

What is the fund size (AUM) of SBI Healthcare Opportunities Fund - Direct Plan Growth?

The Assets Under Management (AUM) of SBI Healthcare Opportunities Fund - Direct Plan Growth is ₹3,989.42 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.

What are the historical returns of SBI Healthcare Opportunities Fund - Direct Plan Growth?

SBI Healthcare Opportunities Fund - Direct Plan Growth has delivered returns of -0.51% (1 Year), 23.94% (3 Year), 17.27% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.

What is the risk level of SBI Healthcare Opportunities Fund - Direct Plan Growth?

SBI Healthcare Opportunities Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.

What is the minimum investment amount for SBI Healthcare Opportunities Fund - Direct Plan Growth?

The minimum lumpsum investment required for SBI Healthcare Opportunities Fund - Direct Plan Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article